View of CHANGES IN SERUM KALLISTATIN LEVELS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE, OBESITY AND KIDNEY DAMAGE INFECTED WITH COVID-19

Return to Issue Details CHANGES IN SERUM KALLISTATIN LEVELS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE, OBESITY AND KIDNEY DAMAGE INFECTED WITH COVID-19 Download Download PDF